TCL Archive Consensus Conference agrees That Nevi Can Be Precursors For Melanoma, Offers Management Suggestions November 4, 1983
TCL Archive In brief: Cancer Investment “Drop In The Bucket,” OMB Is The “Second Greatest Kill,” Pepper Says August 10, 1979
TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012